KOCHER, Martin, Daniel SANAK, Jana ZAPLETOLOVA, Filip CIHLAR, Daniel CZERNY, David CERNIK, Petr DURAS, Jan FIKSA, Jakub HUSTY, Lubomir JURAK, Martin KOVAR, Jiri LACMAN, Radek PADR, Pavel PROCHAZKA, Jan RAUPACH, Martin REISER, Vladimir ROHAN, Martin ROUBEC, Jindrich SOVA, Miroslav SERCL, Miroslav ŠKORŇA, Libor SIMUNEK, Alena SNAJDROVA, Martin SRAMEK a Ales TOMEK. Mechanical Thrombectomy Quality Indicators Study in Czech Stroke Centers: Results of the METRICS Study. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES. AMSTERDAM: ELSEVIER SCIENCE BV, 2022, roč. 31, č. 4, s. 1-6. ISSN 1052-3057. Dostupné z: https://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2022.106308.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Mechanical Thrombectomy Quality Indicators Study in Czech Stroke Centers: Results of the METRICS Study
Autoři KOCHER, Martin (203 Česká republika), Daniel SANAK (203 Česká republika), Jana ZAPLETOLOVA (203 Česká republika), Filip CIHLAR (203 Česká republika), Daniel CZERNY (203 Česká republika, garant), David CERNIK (203 Česká republika), Petr DURAS (203 Česká republika), Jan FIKSA (203 Česká republika), Jakub HUSTY (203 Česká republika), Lubomir JURAK (203 Česká republika), Martin KOVAR (203 Česká republika), Jiri LACMAN (203 Česká republika), Radek PADR (203 Česká republika), Pavel PROCHAZKA (203 Česká republika), Jan RAUPACH (203 Česká republika), Martin REISER (203 Česká republika), Vladimir ROHAN (203 Česká republika), Martin ROUBEC (203 Česká republika), Jindrich SOVA (203 Česká republika), Miroslav SERCL (203 Česká republika), Miroslav ŠKORŇA (203 Česká republika, domácí), Libor SIMUNEK (203 Česká republika), Alena SNAJDROVA (203 Česká republika), Martin SRAMEK (203 Česká republika) a Ales TOMEK (203 Česká republika).
Vydání JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, AMSTERDAM, ELSEVIER SCIENCE BV, 2022, 1052-3057.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30210 Clinical neurology
Stát vydavatele Nizozemské království
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.500
Kód RIV RIV/00216224:14110/22:00128255
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2022.106308
UT WoS 000783573900014
Klíčová slova anglicky Ischemic stroke; Mechanical thrombectomy; Quality indicators; Metrics
Štítky 14110221, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 25. 1. 2023 09:15.
Anotace
Background and purpose: Rigorous and regular evaluation of defined quality indicators is crucial for further improvement of both technical and clinical results after mechanical thrombectomy (MT) for acute ischemic stroke (AIS). Following the recent international multi-society consensus quality indicators, we aimed to assess trend in these indicators on national level. Material and methods: The prospective multicenter study (METRICS) was conducted in Czech Republic (CR) in year 2019. All participating centers collected technical and clinical data including defined quality indicators and results were subsequently compared with those from year 2016. Results: In the 2019, 1375 MT were performed in the CR and 1178 (86%) patients (50.3% males, mean age 70.5 +/- 13.0 years) were analyzed. Recanalization (TICI 2b-3) was achieved in 83.7% of patients and 46.2% of patients had good 3-month clinical outcome. Following time intervals were shortened in comparison to 2016: "hospital arrival - GP" (77 vs. 53 min; p<0.0001), "hospital arrival - maximal achieved recanalization" (122 vs. 93 min; p<0.0001), and "stroke onset - maximal achieved recanalization" (240 vs. 229 min; p p<0.0001). More patients with tandem occlusion were treated in 2019 (7.8 vs. 16.5%; p<0.0001) and more secondary transports were in 2019 (31.3 vs. 37.8%; p=0.002). No difference was found in 3-month clinical outcome and in the rate of periprocedural complications. Results of the METRICS study met all criteria of multi-society consensus quality indicators. Conclusion: Nationwide comparison between 2016 and 2019 showed improvement in the key time intervals, but without better overall clinical outcomes after MT.
VytisknoutZobrazeno: 24. 7. 2024 14:13